Literature DB >> 8150966

Suppression of fungal growth exhibited by Pseudomonas aeruginosa.

J R Kerr1.   

Abstract

Three surgery patients were monitored postoperatively, with particular reference to lung infection. In each case there was a clinical impression that Pseudomonas aeruginosa suppressed the growth of Candida albicans in patients with clinically significant lung infections from whom both of these organisms were isolated from serial sputum samples. Regrowth of C. albicans after P. aeruginosa eradication occurred in two patients, despite fluconazole therapy, to which both C. albicans isolates were susceptible. In all three patients, the strain of P. aeruginosa was found to inhibit the growth of the corresponding C. albicans strain in vitro. Further in vitro susceptibility studies revealed significant inhibition by 10 strains of P. aeruginosa of 11 strains of fungi known to infect humans; these were Candida krusei, Candida keyfr, Candida guillermondii, Candida tropicalis, Candida lusitaniae, Candida parapsilosis, Candida pseudotropicalis, Candida albicans, Torulopsis glabrata, Saccharomyces cerevisiae, and Aspergillus fumigatus.

Entities:  

Mesh:

Year:  1994        PMID: 8150966      PMCID: PMC263067          DOI: 10.1128/jcm.32.2.525-527.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  Invasive candida infections--evolution of a fungal pathogen.

Authors:  J E Edwards
Journal:  N Engl J Med       Date:  1991-04-11       Impact factor: 91.245

2.  Isolation and characterization of a pseudomonas strain that restricts growth of various phytopathogenic fungi.

Authors:  R K Jayaswal; M A Fernandez; R G Schroeder
Journal:  Appl Environ Microbiol       Date:  1990-04       Impact factor: 4.792

3.  Environmental factors affecting the antagonism of Pseudomonas cepacia against Trichoderma viride.

Authors:  R S Upadhyay; L Visintin; R K Jayaswal
Journal:  Can J Microbiol       Date:  1991-11       Impact factor: 2.419

4.  Studies on pyrrolnitrin, a new antibiotic. I. Isolation and properties of pyrrolnitrin.

Authors:  K Arima; H Imanaka; M Kousaka; A Fukuda; G Tamura
Journal:  J Antibiot (Tokyo)       Date:  1965-09       Impact factor: 2.649

5.  Fungal flora of the normal human small and large intestine.

Authors:  R Cohen; F J Roth; E Delgado; D G Ahearn; M H Kalser
Journal:  N Engl J Med       Date:  1969-03-20       Impact factor: 91.245

6.  Evaluation of the in vitro and in vivo antifungal activity of pyrrolnitrin.

Authors:  R S Gordee; T R Matthews
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1967

7.  Systemic antifungal activity of pyrrolnitrin.

Authors:  R S Gordee; T R Matthews
Journal:  Appl Microbiol       Date:  1969-05

8.  Metabolism of tryptophans by Pseudomonas aureofaciens. VI. Production of pyrrolnitrin by selected Pseudomonas species.

Authors:  R P Elander; J A Mabe; R H Hamill; M Gorman
Journal:  Appl Microbiol       Date:  1968-05

9.  Production and characterization of the slime polysaccharide of Pseudomonas aeruginosa.

Authors:  L R Evans; A Linker
Journal:  J Bacteriol       Date:  1973-11       Impact factor: 3.490

10.  Biosynthesis of pyrrolnitrin. Incorporation of 13C, 15N double-labelled D- and L-tryptophan.

Authors:  P Zhou; U Mocek; B Siesel; H G Floss
Journal:  J Basic Microbiol       Date:  1992       Impact factor: 2.281

View more
  30 in total

Review 1.  Skin microbiota: a source of disease or defence?

Authors:  A L Cogen; V Nizet; R L Gallo
Journal:  Br J Dermatol       Date:  2008-03       Impact factor: 9.302

2.  Distinguishing the dominant species of pathogen in ethmoidal sinusitis by sequencing DNA dataset analysis.

Authors:  Junyi Zhang; Shuai He; Yunchuan Li; Minggang Lv; Hongzheng Wei; Bin Qu; Yani Zheng; Chunhua Hu
Journal:  Exp Ther Med       Date:  2018-09-11       Impact factor: 2.447

Review 3.  Medically important bacterial-fungal interactions.

Authors:  Anton Y Peleg; Deborah A Hogan; Eleftherios Mylonakis
Journal:  Nat Rev Microbiol       Date:  2010-03-29       Impact factor: 60.633

4.  Pseudomonas aeruginosa pyocyanin and 1-hydroxyphenazine inhibit fungal growth.

Authors:  J R Kerr; G W Taylor; A Rutman; N Høiby; P J Cole; R Wilson
Journal:  J Clin Pathol       Date:  1999-05       Impact factor: 3.411

5.  Biosynthesis of pyochelin and dihydroaeruginoic acid requires the iron-regulated pchDCBA operon in Pseudomonas aeruginosa.

Authors:  L Serino; C Reimmann; P Visca; M Beyeler; V D Chiesa; D Haas
Journal:  J Bacteriol       Date:  1997-01       Impact factor: 3.490

Review 6.  Pyocyanin: production, applications, challenges and new insights.

Authors:  Sheeba Jayaseelan; Damotharan Ramaswamy; Selvakumar Dharmaraj
Journal:  World J Microbiol Biotechnol       Date:  2013-11-09       Impact factor: 3.312

7.  Pseudomonas aeruginosa inhibits in-vitro Candida biofilm development.

Authors:  H M H N Bandara; J Y Y Yau; R M Watt; L J Jin; L P Samaranayake
Journal:  BMC Microbiol       Date:  2010-04-25       Impact factor: 3.605

8.  Homeostatic interplay between bacterial cell-cell signaling and iron in virulence.

Authors:  Ronen Hazan; Jianxin He; Gaoping Xiao; Valérie Dekimpe; Yiorgos Apidianakis; Biliana Lesic; Christos Astrakas; Eric Déziel; François Lépine; Laurence G Rahme
Journal:  PLoS Pathog       Date:  2010-03-12       Impact factor: 6.823

9.  Pseudomonas aeruginosa-Candida albicans interactions: localization and fungal toxicity of a phenazine derivative.

Authors:  Jane Gibson; Arpana Sood; Deborah A Hogan
Journal:  Appl Environ Microbiol       Date:  2008-11-14       Impact factor: 4.792

10.  Cell wall glycans and soluble factors determine the interactions between the hyphae of Candida albicans and Pseudomonas aeruginosa.

Authors:  Alexandra Brand; Julia D Barnes; Kevin S Mackenzie; Frank C Odds; Neil A R Gow
Journal:  FEMS Microbiol Lett       Date:  2008-08-02       Impact factor: 2.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.